Clinical trial
A Safety and Efficacy Study of Alefacept in the Treatment of Moderate to Severe…
NCT00135733 · Massachusetts General Hospital, Other · Terminated
Key facts
| NCT number | NCT00135733 |
|---|---|
| Title | A Safety and Efficacy Study of Alefacept in the Treatment of Moderate to Severe Erosive Mucosal Lichen Planus |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Pilot Study of the Efficacy and Safety of Alefacept in the Treatment of Moderate to Severe Erosive Mucosal Lichen Planus |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | Brigham and Women's Hospital Stanford University Biogen Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lichen Planus |
| Intervention type | Drug |
| Interventions | Amevive (Alefacept), Placebo |
| Enrollment | 13 |
| Start date | Apr 1, 2004 |
| Primary completion | Dec 1, 2004 |
| Completion | Dec 1, 2004 |
| First posted | Aug 26, 2005 |
| Last update posted | Feb 12, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: